Serum Institute gets nod to resume Oxford COVID vaccine trial in India

Must Read

Good that we are playing strong Mumbai early: KKR captain Karthik

Dinesh Karthik was bought by KKR for Rs 7.4 crore at IPL 2018 auction.IANS Mumbai Indians (MI) consist of world-class players and that is why...

NIA raids at multiple locations in Baramulla, Srinagar in Davinder Singh case

 Baramulla of Jammu and Kashmir.IANS Tightening its noose in the case of suspended J&K Deputy Superintendent of Police (DSP) Davinder Singh and Hizbul Mujahideen terrorist...

The Serum Institute of India has been given a nod by the Drugs Controller General of India (DCGI) Dr V G Somanito resume clinical trial of the Oxford Covid-19 vaccine in the country. DCGI revoked its earlier order of suspending any new recruitment for phase two and three trial.

The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be “scrupulously” followed by Serum Institute of India (SII).

SII has also been asked to submit to the DCGI’s office details of medication used in accordance with the protocol for management of adverse events.

The DCGI had on September 11 directed Serum Institute of India to suspend any new recruitment in the phase two and three clinical trial of the Oxford COVID-19 vaccine candidate till further orders in the backdrop of pharma giant AstraZeneca pausing the clinical trials in other countries because of “an unexplained illness” in a participant in the study.

AstraZeneca and Oxford said clinical trials for their vaccine have resumed in the UK

On Saturday, British-Swedish biopharmaceutical giant AstraZeneca and the University of Oxford said clinical trials for their coronavirus vaccine have resumed in the UK after the Medicines Health Regulatory Authority’s (MHRA) confirmed that the trials were safe.

SII, which has partnered with AstraZeneca for manufacturing the vaccine candidate for COVID-19, on Tuesday submitted the recommendations of the Data and Safety Monitoring Board (DSMB), UK and DSMB, India, and requested for permission to restart enrolment in the clinical trial.

According to Tuesday’s order issued by DCGI, the DSMB, UK, recommended that the investigators recommence all immunization in their clinical trials subject to certain conditions. DSMB, India, also has recommended to continue the study and enroll the remaining participants in the clinical trial as per protocol subject to certain conditions.

coronavirus cases

The WHO reported 71,484 new cases in the United States, 45,403 in Brazil, 34,884 in India and 13,373 in South Africa.Reuters

According to the order, SII has submitted revised participant information sheet, revised informed consent form and additional safety monitoring plan for the evolved participants.

The Pune-based firm has also submitted a summary of safety follow up of seven days post first vaccination, stating that no serious adverse events were experienced by any of the subjects till the date of the reporting, and the reported adverse events were stated to be mild, resolved on their own and did not have any sequale.

“In view of the above, I Dr V G Somani, Drugs Controller General of India, Central Licensing Authority, after careful examination of your reply and the recommendations of the DSMB in India and in UK revoke herewith the order dated September 11 issued under Rule 30 of the New Drugs and Clinical Trials Rules, 2019.

“You may recommence the clinical trial as recommended by DSMB, India, as per already approved protocol and the provisions laid down under the New Drugs and Clinical Trial Rules, 2019, subject to the conditions mentioned,” the order said.

(inputs from wires) 

Source link

Popular

Assam’s Dibrugarh University Teacher Arrested For Sharing Porn Video: Police

During interrogation, the accused confessed to the crime. (Representational)Dibrugarh: An assistant professor in Assam's Dibrugarh University was arrested today for allegedly uploading pornographic content...

Sushant Singh Rajput case | FIR against late actor’s sisters for abetment of his...

Charge comes less than 12 hours after actor Rhea Chakraborty filed a complaint against Sushant’s sisters. The Bandra police station charged late actor Sushant Singh...

MSMEs want extension of loan moratorium

Over 70% of those who have availed loans are not in a position to repay their dues With the loan moratorium period coming to end...

CBI case against 6 companies for allegedly installing pop-ups to personal computers

The Central Bureau of Investigation on Thursday said that it has filed a case against six private companies for allegedly transmitting pop-ups with bogus...

Delhi schools to remain closed for all students till October 5, says Delhi govt

All schools in the national capital will continue to remain closed till October 5 in view of the rising number of the cases, the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles